Lilly Redoubles Fight Against Watson Evista Generic
Doubly determined to prevent incursions by generics makers, Eli Lilly & Co. has filed a second infringement action against Watson Pharmaceuticals Inc. over its effort to develop a knockoff version of...To view the full article, register now.
Already a subscriber? Click here to view full article